News
ALK’s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet
ALK today announced that its partner for Japan, Torii Pharmaceutical Co., Ltd., has agreed a price with authorities and secured a listing on Japan’ s National Health Insurance reimbursement list for its sublingual allergy immunotherapy tablet against Japanese cedar allergy, branded CEDARCURE™. Japan is the world’ s second largest market for allergy medicine,...
ALK today announced that its partner for Japan, Torii Pharmaceutical Co., Ltd., has agreed a price with authorities and secured a listing on Japan’ s National Health Insurance reimbursement list for its sublingual allergy immunotherapy tablet against Japanese cedar allergy, branded CEDARCURE™. Japan is the world’ s second largest market for allergy medicine,...